Mia Furebring

Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study

Heyman, Gabriel; Jonsson, Sofia; Fatsis-Kavalopoulos, Nikos; Hjort, Karin et al.

Ingår i The Lancet Microbe, 2025

• DOI för Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study
• Ladda ner fulltext (pdf) av Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study

Heteroresistance and clinical outcomes: much still to be understood – Authors' reply

Fatsis-Kavalopoulos, Nikos; Heyman, Gabriel; Hjort, Karin; Jonsson, Sofia et al.

Ingår i The Lancet Microbe, 2025

• DOI för Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
• Ladda ner fulltext (pdf) av Heteroresistance and clinical outcomes: much still to be understood – Authors' reply

Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort

Smekal, Anna-Karin; Swartling, Maria; Furebring, Mia; Giske, Christian G et al.

Ingår i Journal of Antimicrobial Chemotherapy, s. 876-884, 2025

• DOI för Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort
• Ladda ner fulltext (pdf) av Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort

Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients

Smekal, Anna-Karin; Swartling, Maria; Nielsen, Elisabet I.; Furebring, Mia et al.

Ingår i Scientific Reports, 2025

• DOI för Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients
• Ladda ner fulltext (pdf) av Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients

Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Swartling, Maria; Hamberg, Anna-Karin; Furebring, Mia; Tängdén, Thomas et al.

Ingår i International Journal of Clinical Pharmacy, s. 178-186, 2025

• DOI för Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
• Ladda ner fulltext (pdf) av Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Heteroresistance and clinical outcomes: much still to be understood – Authors' reply

Fatsis-Kavalopoulos, Nikos; Heyman, Gabriel; Hjort, Karin; Jonsson, Sofia et al.

Ingår i The Lancet Microbe, 2025

• DOI för Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
• Ladda ner fulltext (pdf) av Heteroresistance and clinical outcomes: much still to be understood – Authors' reply

Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort

Smekal, Anna-Karin; Swartling, Maria; Furebring, Mia; Giske, Christian G et al.

Ingår i Journal of Antimicrobial Chemotherapy, s. 876-884, 2025

• DOI för Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort
• Ladda ner fulltext (pdf) av Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort

Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients

Smekal, Anna-Karin; Swartling, Maria; Nielsen, Elisabet I.; Furebring, Mia et al.

Ingår i Scientific Reports, 2025

• DOI för Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients
• Ladda ner fulltext (pdf) av Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients

Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Swartling, Maria; Hamberg, Anna-Karin; Furebring, Mia; Tängdén, Thomas et al.

Ingår i International Journal of Clinical Pharmacy, s. 178-186, 2025

• DOI för Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
• Ladda ner fulltext (pdf) av Model-informed precision dosing of vancomycin in clinical practice: an intervention development study

Nya rekommendationer för infusion av betalaktamantibiotika

Gustafsson, Tove; Eliasson, Erik; Furebring, Mia; Nielsen, Elisabet I. et al.

Ingår i Läkartidningen, 2024

Semi-Conservative Treatment Versus Radical Surgery in Abdominal Aortic Graft and Endograft Infections

Gavali, Hamid; Mani, Kevin; Furebring, Mia; Olsson, Karl Wilhelm et al.

Ingår i European Journal of Vascular and Endovascular Surgery, s. 397-406, 2023

• DOI för Semi-Conservative Treatment Versus Radical Surgery in Abdominal Aortic Graft and Endograft Infections
• Ladda ner fulltext (pdf) av Semi-Conservative Treatment Versus Radical Surgery in Abdominal Aortic Graft and Endograft Infections

Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?

Smekal, Anna-Karin; Furebring, Mia; Lipcsey, Miklós; Giske, Christian G

Ingår i Journal of Antimicrobial Chemotherapy, s. 2895-2901, 2023

• DOI för Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?
• Ladda ner fulltext (pdf) av Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

Kinch, Amelie; Furebring, Mia; Chryssanthou, Erja; Hallböök, Helene

Ingår i Medical Mycology Case Reports, s. 26-30, 2023

• DOI för Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
• Ladda ner fulltext (pdf) av Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

The Microbiology of Infective Native Aortic Aneurysms in a Population-Based Setting

Sorelius, Karl; Wanhainen, Anders; Furebring, Mia; Mani, Kevin et al.

Ingår i Annals of Vascular Surgery, s. 112-122, 2022

• DOI för The Microbiology of Infective Native Aortic Aneurysms in a Population-Based Setting

Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients

Smekal, Anna-Karin; Furebring, Mia; Eliasson, Erik; Lipcsey, Miklós

Ingår i Scientific Reports, 2022

• DOI för Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients
• Ladda ner fulltext (pdf) av Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients

Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury

Lipcsey, Miklós; Bergquist, Maria; Sirén, Rebecca; Larsson, Anders et al.

Ingår i Biomedicines, 2022

• DOI för Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury
• Ladda ner fulltext (pdf) av Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury

Population pharmacokinetics of cefotaxime in intensive care patients

Swartling, Maria; Smekal, Anna-Karin; Furebring, Mia; Lipcsey, Miklós et al.

Ingår i European Journal of Clinical Pharmacology, s. 251-258, 2022

• DOI för Population pharmacokinetics of cefotaxime in intensive care patients
• Ladda ner fulltext (pdf) av Population pharmacokinetics of cefotaxime in intensive care patients

Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Kurland, Siri; Löwdin, Elisabeth; Furebring, Mia; Shams, Ayda et al.

Ingår i Mycoses, s. 79-87, 2022

• DOI för Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?
• Ladda ner fulltext (pdf) av Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Outcome of Radical Surgical Treatment of Abdominal Aortic Graft and Endograft Infections Comparing Extra-anatomic Bypass with In Situ Reconstruction: A Nationwide Multicentre Study

Gavali, Hamid; Mani, Kevin; Furebring, Mia; Olsson, Karl Wilhelm et al.

Ingår i European Journal of Vascular and Endovascular Surgery, s. 918-926, 2021

• DOI för Outcome of Radical Surgical Treatment of Abdominal Aortic Graft and Endograft Infections Comparing Extra-anatomic Bypass with In Situ Reconstruction: A Nationwide Multicentre Study
• Ladda ner fulltext (pdf) av Outcome of Radical Surgical Treatment of Abdominal Aortic Graft and Endograft Infections Comparing Extra-anatomic Bypass with In Situ Reconstruction: A Nationwide Multicentre Study

Branched Endovascular Aortic Plug in Patients With Infrarenal Aortic Graft Infection and Hostile Anatomy

Gavali, Hamid; Mani, Kevin; Furebring, Mia; Mogensen, John et al.

Ingår i Journal of Endovascular Therapy, s. 328-333, 2020

• DOI för Branched Endovascular Aortic Plug in Patients With Infrarenal Aortic Graft Infection and Hostile Anatomy

Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

Kurland, Siri; Furebring, Mia; Löwdin, Elisabeth; Eliasson, E. et al.

Ingår i Antimicrobial Agents and Chemotherapy, 2019

• DOI för Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

Should the Aminoglycoside β-Lactam Combination Be Abandoned in All Severely Ill Patients With Presumed Gram-Negative Infection?

Lipcsey, Miklós; Castegren, Markus; Furebring, Mia; Sjölin, Jan

Ingår i Clinical Infectious Diseases, s. 480-482, 2018

• DOI för Should the Aminoglycoside β-Lactam Combination Be Abandoned in All Severely Ill Patients With Presumed Gram-Negative Infection?

Elimination ability of caspofungin in critically ill patients in relation to liver dysfunction in an ICU setting

Kurland, Siri; Furebring, Mia; Löwdin, Elisabeth; Nielsen, Elisabet I. et al.

Ingår i Mycoses, s. 225-225, 2017

Nationwide Study of the Treatment of Mycotic Abdominal Aortic Aneurysms Comparing Open and Endovascular Repair

Sörelius, Karl; Wanhainen, Anders; Furebring, Mia; Björck, Martin et al.

Ingår i Circulation, s. 1822-1832, 2016

• DOI för Nationwide Study of the Treatment of Mycotic Abdominal Aortic Aneurysms Comparing Open and Endovascular Repair

Korsallergi mellan penicilliner och övriga betalaktam­antibiotikaRisken är betydligt mindre än man tidigare trott: [Cross allergy between penicillins and other beta lactam antibiotics--the risk is much less than previously thought]

Tängdén, Thomas; Furebring, Mia; Löwdin, Elisabeth; Werner, Sonja

Ingår i Läkartidningen, 2015

Aortagraftinfektion – ett komplicerat kärlkirurgiskt tillstånd

Arnelöv, Conny; Furebring, Mia; Wanhainen, Anders

Ingår i Svensk Kirurgi, s. 84-88, 2013

Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients

Lipcsey, Miklós; Furebring, Mia; Rubertsson, Sten; Larsson, Anders

Ingår i Upsala Journal of Medical Sciences, s. 39-46, 2011

• DOI för Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients

Nationellt kvalitetsregister kan ge bättre vård vid livshotande sepsis: [National quality registry can improve care in life-threatening sepsis]

Svefors, Jesper; Vikerfors, Tomas; Furebring, Mia; Lanbeck, Peter et al.

Ingår i Läkartidningen, s. 279-281, 2011

Svår sepsis och septisk chock kräver omedelbart omhändertagande: [Severe sepsis and septic shock require immediate care]

Gårdlund, Bengt; Cronqvist, Jonas; Follin, Per; Furebring, Mia et al.

Ingår i Läkartidningen, s. 271-275, 2011

Neurointensive care of patients with severe community-acquired meningitis

Edberg, M; Furebring, Mia; Sjölin, Jan; Enblad, Per

Ingår i Acta Anaesthesiologica Scandinavica, s. 732-739, 2011

• DOI för Neurointensive care of patients with severe community-acquired meningitis

Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients

Gedeborg, Rolf; Furebring, Mia; Michaëlsson, Karl

Ingår i Journal of Clinical Epidemiology, s. 155-162, 2007

• DOI för Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients

C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.

Furebring, M; Håkansson, L; Venge, P; Sjölin, J

Ingår i Scand J Immunol, s. 208-16, 2006

Subcellular localization and mobolization of carcinoembryonic antigen-related cell adhesion molecule 8 in human neutrophils

Zhao, Linshu; Furebring, Mia; Xu, Shengyuan; Venge, Per

Ingår i British Journal of Haematology, s. 666-673, 2004

• DOI för Subcellular localization and mobolization of carcinoembryonic antigen-related cell adhesion molecule 8 in human neutrophils

Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes

Furebring, Mia; Håkansson, Lena; Venge, Per; Sjölin, Jan

Ingår i Scandinavian Journal of Immunology, s. 494-499, 2004

• DOI för Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes

Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis

Furebring, Mia; Håkansson, Lena Douhan; Venge, Per; Nilsson, Bo et al.

Ingår i Critical Care, s. 363-370, 2002

Rational use of aminoglycosides-Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA)

Hanberger, Håkan; Edlund, Charlotta; Furebring, Mia; G Giske, Christian et al.

Ingår i Scandinavian journal of infectious diseases, s. 161-175, 2013

• DOI för Rational use of aminoglycosides-Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA)

Nationwide study demonstrates paradigm shift in treatment of mycotic abdominal aortic aneurysms

Sörelius, Karl; Wanhainen, Anders; Mia, Furebring; Martin, Björck et al.

Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study

Heyman, Gabriel; Jonsson, Sofia; Fatsis-Kavalopoulos, Nikos; Hjort, Karin et al.

Ingår i The Lancet Microbe, 2025

• DOI för Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study
• Ladda ner fulltext (pdf) av Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study